- £870.90m
- £1.03bn
- $1.06bn
- 89
- 91
- 86
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 698 | 530 | 733 | 952 | 1,061 |
Cost of Revenue | |||||
Gross Profit | 396 | 125 | 285 | 465 | 532 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 386 | 562 | 483 | 677 | 812 |
Operating Profit | 312 | -31.7 | 251 | 275 | 249 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 293 | -80.2 | 177 | 204 | 191 |
Provision for Income Taxes | |||||
Net Income After Taxes | 264 | -85.3 | 117 | 105 | 124 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 277 | -74.7 | 142 | 62.4 | 83.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 277 | -74.7 | 142 | 62.4 | 83.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.529 | -0.001 | 0.176 | 0.117 | 0.141 |
Dividends per Share | |||||
Special Dividends per Share |